PANCREATIC ADENOCARCINOMA
Clinical trials for PANCREATIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for PANCREATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug trial targets Hard-to-Treat tumors
Disease control Not yet recruitingThis study is testing a new drug called ASP546C for people with advanced stomach, pancreatic, and other cancers that have spread or cannot be removed by surgery. The main goals are to find a safe dose and see if the drug can shrink tumors. About 150 participants will receive the …
Matched conditions: PANCREATIC ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Apr 01, 2026 20:11 UTC
-
New drug combo aims to stall deadly pancreatic cancer
Disease control Not yet recruitingThis study is testing whether adding two oral drugs (defactinib and avutometinib) to a precise form of radiation therapy can better control advanced pancreatic cancer and keep it from getting worse. It will involve about 36 adults whose cancer has not progressed after initial che…
Matched conditions: PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New Two-Pronged attack on tough pancreatic cancer begins human testing
Disease control Not yet recruitingThis early-stage study aims to find out if a new two-part treatment is safe for people with locally advanced pancreatic cancer. First, patients receive a precise, high-dose radiation treatment. Then, they receive an experimental immunotherapy drug (PCX12) injected directly into t…
Matched conditions: PANCREATIC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Haoming (Carl) Qiu • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New scan could revolutionize how doctors stage deadly cancers
Diagnosis Not yet recruitingThis study is testing a new type of PET scan to see if it is better than current CT and MRI scans at finding out how far pancreatic or bile duct cancer has spread. The goal is to help doctors make more accurate treatment decisions from the start. The study will involve 120 patien…
Matched conditions: PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Mar 31, 2026 12:11 UTC